Fibrin Glue Market to Grow at a Brisk rate in the Foreseeable Future

The fibrin glue market is expected to grow at a CAGR of 10.9% between 2017-2023, to reach $3.6 billion by 2023. Rising healthcare expenditure, increasing number of surgical procedures and burn cases are some of the key factors, driving the growth of the growth. Additionally, increasing prevalence of chronic diseases, aging population, low chances of complications associated with these products and increase in road accidents also support the growth of the global market.

Get a Sample Copy of this Report at: https://www.psmarketresearch.com/market-analysis/fibrin-glue-market/report-sample

Fibrin glue is made up of thrombin and fibrinogen which is applied on the tissue site for gluing them together. It is used in wound closure, bronchial fistulas, achieving hemostasis in liver and spleen trauma, and dura tears. Fibrin glue has sealing and hemostatic properties that help in gluing the tissues during a surgery. In clinical use, fibrin glue provides adequate tissue adhesion and shows quick hemostasis. The chances of complications during surgeries are quite less, with the use of fibrin glue. It reduces postoperative bleeding, postoperative scars, and infection when impregnated with antibiotics. As compared to sutures, fibrin glue causes less inflammation, faster surface rehabilitation, and less discomfort to the patient. Moreover, using fibrin glue in surgeries causes less post-operative pain, since the biomaterials of the fibrin glue are not toxic, inflammatory and allergenic. All the above factors associated with the use of fibrin glue, eventually lead to lower complications in various surgical procedures, thereby driving the growth of the fibrin glue market.

Europe is the second largest market for fibrin glue products, accounting for 24.4% of the global fibrin glue industry in 2016. The growth in the European fibrin glue market is mainly attributable to the increasing aging population and rising number of surgical procedures performed for the treatment of the circulatory system diseases in the region. Among the countries in Europe, Germany held the largest share of the European market for fibrin glue, contributing 26.2% in 2016. However, the market in France is expected to witness the highest growth during the forecast period. France was also the second largest market for fibrin glue products in 2016 in Europe, accounting for a 14.6% share, which is expected to increase to 15.5% by 2023, growing at a CAGR of 10.7% during the forecast period. The U.K. is the third largest market in Europe and is also expected to witness double digit growth during the forecast period.

Browse report at: https://www.psmarketresearch.com/market-analysis/fibrin-glue-market

Some of the key players operating in the global fibrin glue market include Vivostat A/S, Kaketsuken, Johnson & Johnson, Baxter International Inc., CSL Behring, Zimmer Biomet Holdings, Inc., Takeda Pharmaceutical Company Limited, Mallinckrodt Plc, Shanghai RAAS Blood Products Co. Ltd. and Hualan Biological Engineering Inc.

Source: P&S Intelligence

Molecular Biology Kits & Reagents and Enzymes Market Size 2022

The molecular biology kits and reagents and enzymes market is expected to reach $15.0 billion by 2022, growing at a CAGR of 17.2% between 2016-2022. The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample

In terms of product, the molecular biology kits & reagents and enzymes market has been segmented into kits & reagents and enzymes. The kits & reagents segment led the molecular biology kits & reagents and enzymes industry in 2015, and it is expected to witness higher growth compared to enzymes, during 2016 - 2022.

In terms of application, the molecular biology kits & reagents and enzymes market has been segmented into PCR, sequencing, cloning, epigenetic, restriction digestion, synthetic biology, and others. The PCR was the largest application of the molecular biology kits & reagents and enzymes industry in 2015, and sequencing is expected to witness the highest growth during 2016 - 2022.

In terms of end user, the molecular biology kits & reagents and enzymes market has been segmented into academic & research institute, hospital & diagnostic center, pharmaceutical & biotechnology company, and others (small clinics, cell banks and forensic labs). The academic & research institute segment was the largest segment in the molecular biology kits & reagents and enzymes market in 2015, and hospital & diagnostic center segment is expected to witness the highest growth during 2016 - 2022.

Browse report at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market

Some of the competitors in the molecular biology kits & reagents and enzymes market are Thermo Fisher Scientific, Inc., Merck KGAA, Qiagen N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Promega Corporation, New England Biolabs, Inc., Illumina, Inc. and Takara Bio Inc.

Source: P&S Intelligence

Middle East Dermal Fillers Market Insights, Share, Growth and Forecast by 2023

Middle East dermal fillers market is forecasted to generate a revenue of $67.7 million by 2023. The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market/report-sample

On the basis of the type of dermal fillers, the market is categorized into hyaluronic acid-based, hydroxylapatite-based, synthetic polymer-based, and collagen-based fillers. Till now, hyaluronic acid-based fillers have been accounting for the largest share in the dermal fillers market of the Middle East. It is also expected to be the fastest growing category during the forecast period. This can be mainly attributed to the ability of these tissue fillers to attract water molecules, which aids in hydration and increasing skin volume.

On the basis of application, the dermal fillers market in the Middle East has been segmented into facial line correction, face lift, lip treatment, and others. Facial line correction has been holding the largest share in the dermal fillers market, with an estimated revenue contribution of 45.6% in 2017. It is also expected to be the fastest growing category during the forecast period, due to increasing number of patients opting for this treatment.

Browse report at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market

In the Middle East, key players in the dermal fillers industry are launching tissue fillers based on hyaluronic acid to gain a larger market share. For instance, in March 2018, Galderma S.A. in collaboration with AMCo Group and Medica Group, launched two Restylane hyaluronic acid fillers in Saudi Arabia, namely Restylane Refyne and Restylane Defyne. Some of the other major players operating in the dermal fillers market include Allergan plc, Merz Pharma GmbH & Co. KGaA, Sinclair Pharma plc, and Teoxane Laboratories.

Source: P&S Intelligence